Non-Uptake of Predictive Genetic Testing for BRCA1/2 among Relatives of Known Carriers: Attributes, Cancer Worry, and Barriers to Testing in a Multicenter Clinical Cohort

Genetic Testing

Volumn 8, Issue 1, 2004, Pages 23-29

  Foster, C ^a   Evans, D G R ^b   Eeles, R ^c   Eccles, D ^d   Ashley, S ^c   Brooks, L ^b   Cole, T ^e   Cook, J ^f   Davidson, R ^g   Gregory, H ^h   Mackay, J ⁱ   Morrison, P J ^j   Watson, M ^a,c  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^d PRINCESS ANNE HOSPITAL   (United Kingdom)

^e BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

^f SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^g NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

^h UNIVERSITY OF ABERDEEN   (United Kingdom)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

^j BELFAST CITY HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN;

ADULT; ARTICLE; CANCER; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; COHORT ANALYSIS; CONTROLLED STUDY; FAMILY; FEMALE; GENE IDENTIFICATION; GENETIC COUNSELING; GENETIC SCREENING; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCOGENE; OUTPATIENT DEPARTMENT; POPULATION; PREDICTION; QUESTIONNAIRE; SEX DIFFERENCE; SOCIAL PSYCHOLOGY; TIME; UNITED KINGDOM; WORK;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MIDDLE AGED;

EID: 11144355154     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/109065704323016003     Document Type: Article

References (18)

1. ALAGNA, S.W., MOROKOFF, P.J., BEVETT, J.M., and REDDY, D.M. (1987). Performance of breast self examination by women at risk for breast cancer. Women and Health 12, 29-46.
2. BROOKS, L., LENNARD, F., SHENTON, A., LALLOO, F., AMBUS, I., ARDERN-JONES, A., BELK, R., KERR, B., CRAUFURD, D., EELES, R., and EVANS, D.G., BRCA1/2 predictive testing: A study of uptake in two centers. Eur. J. Hum. Genet. (in press).
3. DEPARTMENT OF HEALTH. (2001). Government response to the report from the House of Commons Science and Technology Committee: Genetics and Insurance: Department of Health.
4. EASTON, D., STEELE, L., FIELDS, P., ORMISTON, W., AVERILL, D., DALY, P., McMANUS, R., NEUHAUSEN, S., FORD, D., WOOSTER, R., CANNON-ALBRIGHT, L., STRATTON, M., and GOLDGAR, D. (1997). Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am. J. Hum. Genet. 61, 120-128.
5. FORD, D., EASTON, D., STRATTON, M., NAROD, S., GOLDGAR, D., DEVILEE, P., BISHOP, D., WEBER, B., LENOIR, G., CHANG-CLAUDE, J., SOBOL, H., TEARE, M., STRUEWING, J., ARASON, A., SCHERNECK, S., PETO, J., REBBECK, T., TONIN, P., NEUHAUSEN, S., BARKARDOTTIR, R., EYFJORD, J., LYNCH, H., PONDER, B., GAYTHER, S., BIRCH, J., LINDBLOM, A., STOPPA-LYONNET, D., BIGNON, Y., BORG, A., HAMANN, U., HAITES, N., SCOTT, R., MAUGARD, C., VASEN, H., SEITZ, S., CANNON-ALBRIGHT, L., SCHOFIELD, A., ZELADA-HEDMAN, M., and THE BREAST CANCER LINKAGE CONSORTIUM. (1998). Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am. J. Hum. Genet. 62, 676-689.
6. FOSTER, C., EVANS, D.G.R., EELES, R., ECCLES, D., ASHLEY, S., BROOKS, L., DAVIDSON, R., MACKAY, J., MORRISON, P.J., and WATSON, M. (2002a). Predictive testing for BRCA1/2: attributes, risk perception and management in a multi-centre clinical cohort. Br. J. Cancer 86, 1209-1216.
7. FOSTER, C., WATSON, M., MOYNIHAN, C., ARDERN-JONES, A., and EELES, R. (2002b). Genetic testing for breast and ovarian cancer predisposition: Cancer burden and responsibility. J. Health Psychol. 7, 469-484.
8. HARTMANN, L.C., SELLERS, T.A., SCHAID, D.J., FRANK, T.S., SODERBERG, C.L., SITTA, S.L., FROST, M.H., GRANT, C.S., DONOHUE, J.H., WOODS, J.E., McDONNELL, S.K., VOCKLEY, C.W., DEFFENBAUGH, A., COUCH, F.J., and JENKINS, R.B. (2001). Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J. Natl. Cancer Inst. 93, 1633-1637.
9. HENDRICK, R., SMITH, R., RUTLEDGE, J.R., and SMART, C. (1997). Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. J. Natl. Cancer Inst. Monogr. 22, 87-92.
10. KASH, K.M., HOLLAND, J.C., HALPER, M.S., and MILLER, D.G. (1992). Psychological distress and surveillance behaviours of women with a family history of breast cancer. J. Natl. Cancer Inst. 84, 24-30.
11. LERMAN, C., and SCHWARTZ, M. (1993). Adherence and psychological adjustment among women at high-risk for breast-cancer. Breast Cancer Res. Treat. 28, 145-155.
12. LERMAN, C., HUGHES, C., LEMON, S.J., MAIN, D., SNYDER, C., DURHAM, C., NAROD, S., and LYNCH, H.T. (1998). What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing. J. Clin. Oncol. 16, 1650-1654.
13. LLOYD, S., WATSON, M., WAITES, B., MEYER, L., EELES R., EBBS, S., and TYLEE, A. (1996). Familial breast cancer: a controlled study of risk perception, psychological morbidity and health beliefs in women attending for genetic counseling. Br. J. Cancer 74, 482-487.
14. LODDER, L.N., FRETS, P.G., TRIJSBURG, R.W., MEIJERS-HEIJBOER, E.J., KLIJN, J.G.M., DUIVENVOORDEN, H.J., TIBBEN, A., WAGNER, A., VAN DER MEER, C.A., DEVILEE, P., CORNELISSE, C.J., and NIERMEIJER, M.F. (1999). Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? J. Med. Genet. 36, 906-913.
15. MIKI, Y., SWENSEN, J., SHATTUCK EIDENS, D., FUTREAL, P.A., HARSHMAN, K., TAVTIGIAN, S., LIU, Q., COCHRAN, C., BENNETT, L., DING, W., BELL, R., ROSENTHAL, J., HUSSEY, C., TRAN, T., McCLURE, M., FRYE, C., HATTIER, T., PHELPS, R., HAUGENSTRANO, A., KATCHER, H., YAKUMO, K., GHOLAMI, Z., SHAFFER, D., STONE, S., BAYER, S., WRAY, C., BOGDEN, R., DAYANANTH, P., WARD, J., TONIN, P., NAROD, S., BRISTOW, P., NORRIS, F., HELVERLING, L., MORRISON, P., ROSTECK, P., LAI, M., BARRETT, J., LEWIS, C., NEUHAUSEN, S., CANNON-ALBRIGHT, L., GOLDGAR, D., WISEMAN, R., KAMB, A., and SKOLNICK, M., (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66-71.
16. REBBECK, T.R., LYNCH, H.T., NEUHAUSEN, S.L., NAROD, S.A., VAN'T VEER, L., GARBER, J.E., EVANS, G., ISAACS, C., DALY, M.B., MATLOFF, E., OLOPADE, O.I., WEBER, B.L., and the PREVENTION AND OBSERVATION OF SURGICAL END POINTS STUDY GROUP (2002). Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N. Engl. J. Med. 346,1616-1622.
17. WONDERLING, D., HOPWOOD, P., CULL, A., DOUGLAS, F., WATSON, M., BURN, J., and McPHERSON, K. (2001). A descriptive study of UK cancer genetics services: an emerging clinical response to the new genetics. Br. J. Cancer 85, 166-170.
18. WOOSTER, R., BIGNELL, G., LANCASTER, J., SWIFT, S., SEAL, S., MANGION, J., COLLINS, N., GREGORY, S., GUMBS, C., and MICKLEM, G. (1995). Identification of the breast susceptibility gene BRCA2. Nature 378, 789-791.